News
Pharmaceutical Technology on MSN22h
Novo Nordisk’s Sogroya matches Norditropin in children’s growth disordersNovo Nordisk’s once-weekly Sogroya (somapacitan) has proved to be non-inferior to the once-daily growth hormone Norditropin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback